15-22999743-T-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_052903.6(TUBGCP5):c.*77A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.116 in 1,500,206 control chromosomes in the GnomAD database, including 13,648 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1817 hom., cov: 33)
Exomes 𝑓: 0.11 ( 11831 hom. )
Consequence
TUBGCP5
NM_052903.6 3_prime_UTR
NM_052903.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.33
Genes affected
TUBGCP5 (HGNC:18600): (tubulin gamma complex component 5) Enables microtubule binding activity. Involved in microtubule nucleation. Located in centrosome and cytosol. Part of gamma-tubulin large complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-22999743-T-C is Benign according to our data. Variant chr15-22999743-T-C is described in ClinVar as [Benign]. Clinvar id is 1270324.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.443 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBGCP5 | ENST00000615383 | c.*77A>G | 3_prime_UTR_variant | Exon 23 of 23 | 1 | NM_052903.6 | ENSP00000480316.1 | |||
TUBGCP5 | ENST00000614508.4 | n.3028+826A>G | intron_variant | Intron 22 of 23 | 5 | ENSP00000484566.1 |
Frequencies
GnomAD3 genomes AF: 0.135 AC: 20454AN: 151926Hom.: 1813 Cov.: 33
GnomAD3 genomes
AF:
AC:
20454
AN:
151926
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.114 AC: 153142AN: 1348162Hom.: 11831 Cov.: 19 AF XY: 0.112 AC XY: 76065AN XY: 676244
GnomAD4 exome
AF:
AC:
153142
AN:
1348162
Hom.:
Cov.:
19
AF XY:
AC XY:
76065
AN XY:
676244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.135 AC: 20477AN: 152044Hom.: 1817 Cov.: 33 AF XY: 0.136 AC XY: 10086AN XY: 74336
GnomAD4 genome
AF:
AC:
20477
AN:
152044
Hom.:
Cov.:
33
AF XY:
AC XY:
10086
AN XY:
74336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
814
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jun 19, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at